ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

H9

Hospital 9 de Julho at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Hospital 9 de Julho takes part in 3 sessions at ESMO 2026 in Madrid. Its research addresses inherited cancer risk and access to biomarker testing. It examines genetic screening needs in an Amazonian breast cancer population and barriers to testing in head and neck cancer.

OrganizationESMO 2026 Attendance
H9
Hospital 9 de Julho
São Paulo, Brazil
Cancer centre & hospital
Hospital in São Paulo, Brazil.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Real-world adoption and systemic barriers to biomarker testing in head and neck cancers (HNC): Results from the Brazilian SHINE survey (LACOG 0225-GBCP)
ePoster session 18
Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Poster
Sun Oct 25
12:00–12:45

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Hospital 9 de Julho

Tell us what you sell and we’ll find the people at Hospital 9 de Julho most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction